Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RETeval All Comers Trial (REACT)

NCT03065881 is registered in ClinicalTrials.gov with LKC Technologies, Inc. as lead sponsor.

NCT NCT03065881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03065881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RETeval All Comers Trial (REACT)
Lead sponsor
LKC Technologies, Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 13, 2017
Completion date
December 21, 2021
Enrollment
664 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinal disease, electroretinogram